These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7019034)

  • 1. Preparation and biological properties of [LeuB24, LeuB25]human insulin.
    Jonczyk A; Keefer LM; Naithani VK; Gattner HG; De Meyts P; Zahn H
    Hoppe Seylers Z Physiol Chem; 1981 May; 362(5):557-61. PubMed ID: 7019034
    [No Abstract]   [Full Text] [Related]  

  • 2. Semisynthesis and biological activity of porcine [LeuB24]insulin and [LeuB25]insulin.
    Tager H; Thomas N; Assoian R; Rubenstein A; Saekow M; Olefsky J; Kaiser ET
    Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3181-5. PubMed ID: 6997872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between negative cooperativity and insulin action.
    Olefsky JM; Green A; Ciaraldi TP; Saekow M; Rubenstein AH; Tager HS
    Biochemistry; 1981 Jul; 20(15):4488-92. PubMed ID: 7025901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [LeuB24]- and [LeuB25]insulins are not antagonists of lipogenesis in adipocytes.
    Diaconescu C; Saunders D; Gattner HG; Brandenburg D
    Hoppe Seylers Z Physiol Chem; 1982 Feb; 363(2):187-92. PubMed ID: 7037593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-function relationships of shortened [LeuB25]insulins, semisynthetic analogues of a mutant human insulin.
    Fischer WH; Saunders D; Brandenburg D; Diaconescu C; Wollmer A; Dodson G; De Meyts P; Zahn H
    Biol Chem Hoppe Seyler; 1986 Sep; 367(9):999-1006. PubMed ID: 3539147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [B17-D-leucine]insulin and [B17-norleucine]insulin: synthesis and biological properties.
    Knorr R; Danho W; Büllesbach EE; Gattner HG; Zahn H; King GL; Kahn CR
    Hoppe Seylers Z Physiol Chem; 1983 Nov; 364(11):1615-26. PubMed ID: 6363268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supernormal insulin: [D-PheB24]-insulin with increased affinity for insulin receptors.
    Kobayashi M; Ohgaku S; Iwasaki M; Maegawa H; Shigeta Y; Inouye K
    Biochem Biophys Res Commun; 1982 Jul; 107(1):329-36. PubMed ID: 6751328
    [No Abstract]   [Full Text] [Related]  

  • 8. Internalization and degradation of a low affinity insulin ([LeuB24]insulin) by rat adipocytes.
    Green A; Tager H; Rubenstein A; Frank B; Olefsky JM
    FEBS Lett; 1982 Aug; 144(2):255-8. PubMed ID: 6749549
    [No Abstract]   [Full Text] [Related]  

  • 9. Semisynthesis and biological properties of the [B24-leucine]-, [B25-leucine[- and [B24-leucine, B25-leucine]-analogues of human insulin.
    Inouye K; Watanabe K; Tochino Y; Kanaya T; Kobayashi M; Shigeta Y
    Experientia; 1981; 37(8):811-3. PubMed ID: 7026270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iodinated [A1-N gamma-(4-azidophenylacetyl)-D-alpha, gamma-diaminobutyric acid]insulin: its preparation and properties.
    Saunders DJ; Brandenburg D
    Hoppe Seylers Z Physiol Chem; 1981 Sep; 362(9):1237-45. PubMed ID: 7049887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photoaffinity labeling of insulin receptor with an insulin analogue selectively modified at the amino terminal of the B chain.
    Yeung CW; Moule ML; Yip CC
    Biochemistry; 1980 May; 19(10):2196-203. PubMed ID: 6990974
    [No Abstract]   [Full Text] [Related]  

  • 12. Impaired negative cooperativity of the semisynthetic analogues human [LeuB24]- and [LeuB25]-insulins.
    Keefer LM; Piron MA; De Meyts P; Gattner HG; Diaconescu C; Saunders D; Brandenburg D
    Biochem Biophys Res Commun; 1981 Jun; 100(3):1229-36. PubMed ID: 7023479
    [No Abstract]   [Full Text] [Related]  

  • 13. The endocytotic-internalization pathway of insulin metabolism: relationship to insulin degradation and activation of glucose transport.
    Marshall S; Olefsky JM
    Endocrinology; 1980 Dec; 107(6):1937-45. PubMed ID: 7000505
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of insulin fragments on biological activity of insulin and desoctapeptide insulin. II. Enhanced binding and mechanism studies.
    Kikuchi K; Larner J; Freer RJ; Day AR
    J Biol Chem; 1981 Sep; 256(18):9445-9. PubMed ID: 7026554
    [No Abstract]   [Full Text] [Related]  

  • 15. Preparation and biological properties of glycosylated insulin.
    Dolhofer R; Wieland OH
    FEBS Lett; 1979 Apr; 100(1):133-6. PubMed ID: 437095
    [No Abstract]   [Full Text] [Related]  

  • 16. Characterization of insulin-induced receptor loss and evidence for internalization of the insulin receptor.
    Marshall S; Olefsky JM
    Diabetes; 1981 Sep; 30(9):746-53. PubMed ID: 7021273
    [No Abstract]   [Full Text] [Related]  

  • 17. The chemical synthesis and biological evaluation of [1-L-alanine-A]-and [1-D-alanine-A]insulins.
    Cosmatos A; Cheng K; Okada Y; Katsoyannis PG
    J Biol Chem; 1978 Sep; 253(18):6586-90. PubMed ID: 681368
    [No Abstract]   [Full Text] [Related]  

  • 18. [LeuB24]insulin and [AlaB24]insulin: altered structures and cellular processing of B24-substituted insulin analogs.
    Assoian RK; Thomas NE; Kaiser ET; Tager HS
    Proc Natl Acad Sci U S A; 1982 Sep; 79(17):5147-51. PubMed ID: 6752939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutant insulin syndrome: identification of two families with [LeuA3]insulin and determination of its biological activity.
    Nanjo K; Sanke T; Kondo M; Nishimura S; Miyano M; Linuma J; Miyamura K; Inouye K; Given BD; Polonsky KS
    Trans Assoc Am Physicians; 1986; 99():132-42. PubMed ID: 3299984
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of colchicine and vinblastine on the coupling of insulin binding and insulin action in fat cells.
    Häring HU; Kemmler W; Hepp KD
    FEBS Lett; 1979 Sep; 105(2):329-32. PubMed ID: 488360
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.